Anzeige
Mehr »
Login
Dienstag, 14.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
322 Leser
Artikel bewerten:
(1)

Perimeter Medical Imaging Appoints Tom Boon as New CEO, Jeremy Sobotta for CFO Position

Finanznachrichten News

New leadership roles will strengthen ties between new Texas headquarters and PMI partners in the medical field.

DALLAS, TX / ACCESSWIRE / April 28, 2020 / Perimeter Medical Imaging, a Medical Imaging and AI company, today announces the appointment of Tom Boon as CEO and Jeremy Sobotta as CFO. This announcement comes shortly after the opening of the Toronto-based company's Texas headquarters under the name Perimeter Medical Imaging AI.

Mr. Boon brings extensive experience in the diagnostic imaging industry to his role as CEO. As diagnostic imaging is a major part of breast cancer screening, detection, diagnosis and surgery, Mr. Boon's senior leadership roles in the areas of manufacturing, quality and regulatory, sales and product management will be advantageous to his role at PMI. Mr. Boon has previously worked with medical device companies including Imaging Dynamics Company Ltd, Del Medical Systems Group, and Agfa Healthcare. His dedication to the mission at PMI is a personal one, as his daughter is a breast cancer survivor. Prior to joining PMI, Mr. Boon served as President of Summit Industries for nearly 10 years.

"I'm looking forward to establishing clinical trials in Texas and building the business operations for PMI in the Dallas- Fort Worth area," said Mr. Boon "Working with Jeremy, along with our entire team in Toronto, will help us ensure successful clinical and commercial outcomes for our partners and future customers throughout the state, in a way that can truly advance healthcare outcomes for breast cancer patients."

CFO Jeremy Sobotta comes to PMI with a diverse background in all areas of finance in the medical devices industry supporting many different geographies and go-to-market models. To date, Mr. Sobotta has been a part of the deployment of over $4 billion in capital over his career in acquisitions. His most recent role was as Head of Finance for the Stryker business unit responsible for surgical equipment and women's health. This wide background of experience made him an ideal fit for the role of CFO, particularly as the company expands its operations into new partnerships.

"With the expansion of commercial operations, this is simply a great opportunity to get in on the ground floor of a growing organization," Mr. Sobotta said in a statement. "From our Dallas headquarters, we'll be establishing sales coordination with our partners in addition to clinical research and product development. It's an exciting time to be a part of this - we're eager to continue our medical imaging and AI innovations along with our partners and the rest of the PMI team."

Both Mr. Boon and Mr. Sobotta are based in Dallas, Texas, the new headquarters of Perimeter Medical Imaging AI Corp. This expansion allows PMI to work closer with their Texas-based healthcare partners, including Baylor Medical Center, MD Anderson and others.

About Perimeter

Perimeter is a private Toronto-headquartered company that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is an FDA-cleared point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment by clinician sight or physical inspection for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system.

In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review.

SOURCE: Perimeter Medical Imaging



View source version on accesswire.com:
https://www.accesswire.com/587202/Perimeter-Medical-Imaging-Appoints-Tom-Boon-as-New-CEO-Jeremy-Sobotta-for-CFO-Position

© 2020 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.